Concord Medical Services Holdings (CCM) Cash & Equivalents (2009 - 2025)

Concord Medical Services Holdings (CCM) has reported Cash & Equivalents for 17 consecutive years, with $42.0 million the latest figure, recorded in Q4 2025.

• Cash & Equivalents for Q4 2025 came in at $42.0 million, up 39.48% year-over-year; the trailing twelve-month figure through Dec 2025 was $42.0 million (up 39.48% YoY), and the FY2025 annual result was $42.6 million, up 43.75% from the prior year.
• Cash & Equivalents was $42.0 million for Q4 2025 at Concord Medical Services Holdings, down from $24.8 billion in the prior quarter.
• Over five years, Cash & Equivalents peaked at $38.2 billion in Q2 2021 and troughed at $8.1 million in Q4 2023.
• Average Cash & Equivalents over 5 years is $9.0 billion, with a median of $38.4 million recorded in 2023.
• Year-over-year, Cash & Equivalents soared 47678.54% in 2021 and tumbled 99.69% in 2023.
• Over 5 years, Cash & Equivalents stood at $24.9 million in 2021, then fell by 9.86% to $22.4 million in 2022, then sank by 63.96% to $8.1 million in 2023, then surged by 272.79% to $30.1 million in 2024, then soared by 39.48% to $42.0 million in 2025.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $42.0 million in Q4 2025, $24.8 billion in Q2 2025, and $30.1 million in Q4 2024.